Neurology®
The most widely read and highly cited peer-reviewed Neurology journal
Quick Search
Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, L. B.
Right arrow Articles by Davis, J. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goldstein, L. B.
Right arrow Articles by Davis, J. N.
NEUROLOGY 1988;38:1806
© 1988 American Academy of Neurology

Physician prescribing patterns following hospital admission for ischemic cerebrovascular disease

Larry B. Goldstein, MD and James N. Davis, MD

Neurology Research Laboratory, Durham VA Medical Center, and Departments of Medicine (Neurology) and Pharmacology, Duke University, Durham, NC.

Functional recovery after brain injury in laboratory animals is influenced by a variety of drugs. Yet, the impact of currently prescribed drugs on recovery after human stroke remains largely unexplored. From the Duke-VA Stroke Registry, we found 77% of patients admitted to either the university hospital or the Veterans Administration hospital with cerebral infarction were taking medications at the time of their stroke. Ninety-five percent of these patients were receiving medication at the time of discharge. Antihypertensives were the most commonly prescribed agents in the study population, and platelet antiaggregants were second. Sixty-four percent of patients had a change in their antihypertensive regimens. The number of patients prescribed sedative-hypnotic agents doubled over the first 48 hours after hospital admission. The choice of a therapeutic agent for a given clinical indication may have important implications for rehabilitation of the stroke patient.

Address correspondence and reprint requests to Dr. Goldstein, Building 16, Room 29, Durham VA Medical Center, Durham, NC 27705.

Supported by the Veterans Administration and the NIH (NS 01162, NS 06233).

Received March 30, 1988. Accepted for publication in final form April 25, 1988.




This article has been cited by other articles:


Home page
StrokeHome page
L. B. Goldstein
The 2009 Feinberg Lecture: The Continuum of Stroke Research and Policy
Stroke, December 1, 2009; 40(12): 3879 - 3882.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
L. B. Goldstein and S. Bullman
Differential Effects of Haloperidol and Clozapine on Motor Recovery after Sensorimotor Cortex Injury in Rats
Neurorehabil Neural Repair, December 1, 2002; 16(4): 321 - 325.
[Abstract] [PDF]


Home page
StrokeHome page
D. J. Gladstone, S. E. Black, and A. M. Hakim
Toward Wisdom From Failure: Lessons From Neuroprotective Stroke Trials and New Therapeutic Directions
Stroke, August 1, 2002; 33(8): 2123 - 2136.
[Abstract] [Full Text] [PDF]


Home page
Neurorehabil Neural RepairHome page
D. C. Good
Treatment Strategies for Enhancing Motor Recovery in Stroke Rehabilitation
Neurorehabil Neural Repair, January 1, 1994; 8(4): 177 - 186.
[Abstract] [PDF]


Home page
Neurorehabil Neural RepairHome page
L. B. Goldstein
Pharmacologic Modulation of Recovery After Stroke: Clinical Data
Neurorehabil Neural Repair, January 1, 1991; 5(1-2): 129 - 140.
[PDF]


Home page
Neurorehabil Neural RepairHome page
L. B. Goldstein, D. B. Matchar, J. C. Morgenlander, and J. N. Davis
Influence of Drugs on the Recovery of Sensorimotor Function After Stroke
Neurorehabil Neural Repair, January 1, 1990; 4(3): 137 - 144.
[Abstract] [PDF]


Home page
Arch NeurolHome page
B. H. Dobkin
Focused Stroke Rehabilitation Programs Do Not Improve Outcome
Arch Neurol, June 1, 1989; 46(6): 701 - 703.
[Abstract] [PDF]